Divi's Laboratories Ltd. (DIVISLAB) Share Price Hits Fresh 52-Week High

Divi's Laboratories Ltd. Share Price reaches a fresh 52-week high at Rs 7,860.5, marking a 0.85% increase today. The market cap stands at Rs 1,96,989.63 Cr.

Divi's Laboratories Ltd. Share Price has achieved a fresh 52-week high, reaching Rs 7,860.5. This marks a 0.85% increase from the previous close of Rs 7,794. The company's market capitalisation is Rs 1,96,989.63 Cr, highlighting its significant presence in the healthcare sector. The current price action reflects investor interest, although the data does not specify a company-specific catalyst for this movement. Univest continues to monitor the stock for further developments.

Divi's Laboratories Ltd. Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 7,860.5
Previous Close	Rs 7,794
Today's Change	+Rs 66.5 (+0.85%)
Day Open	Rs 7,864.3
Fresh 52-Week High	Rs 7,886.55
Day Low	Rs 7,815
Current Volume	2,430
Turnover	Rs 1.91 crore
Market Capitalisation	Rs 1,96,989.63 crore

Divi's Laboratories Ltd. (DIVISLAB) traded at Rs 7,860.5. versus the previous close of Rs 7,794, a rise of 0.85%. The stock opened at Rs 7,864.3, reached Rs 7,886.55, touched Rs 7,815. Reported volume was 2,430.

Today, Divi's Laboratories Ltd. opened at Rs 7,864.3 and reached a high of Rs 7,886.55, setting a new 52-week peak. The stock's low for the day was Rs 7,815, with a turnover of Rs 1.91 Cr. The current volume of 2,430 shares indicates moderate trading activity. This price action suggests a positive sentiment among investors, as the stock continues to perform well within its sector.

Divi's Laboratories Ltd. (DIVISLAB) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 1,96,989.63 crore
P/E Ratio	30.28x
P/B Ratio	0.44x
ROE	-2.89%
ROCE	-0.26%

Divi's Laboratories Ltd. was valued at a P/E ratio of 30.28x, a P/B ratio of 0.44x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Company P/E Ratio	30.28x
Benchmark Median P/E	21.7x
Benchmark Average P/E	68.16x
Benchmark P/E Range	0x to 3,385.56x
Company P/B Ratio	0.44x
Benchmark Median P/B	1.9x
Company ROE	-2.89%
Benchmark Median ROE	10.73%
Company ROCE	-0.26%
Benchmark Median ROCE	13.2%
Company Market Capitalisation	Rs 1,96,989.63 crore
Benchmark Median Market Cap	Rs 138.42 crore

Divi's Laboratories Ltd. (DIVISLAB) is classified under sector: Healthcare.

Divi's Laboratories Ltd. (DIVISLAB) has a P/E ratio of 30.28x, which is above the benchmark median of 21.7x, a difference of +39.54%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Divi's Laboratories Ltd. (DIVISLAB) has a ROE of -2.89%, which is below the benchmark median of 10.73%, a difference of -126.93%. Divi's Laboratories Ltd. (DIVISLAB) has a ROCE of -0.26%, which is below the benchmark median of 13.2%, a difference of -101.97%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,856.59	30.28	0.44	-2.89	-0.26
Kwality Pharmaceuticals Ltd.	KPL	2,686.76	40.11	8.17	28.21	26.35
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,432.22	34.7	7.02	-2.6	16.92
Sai Parenteral's Ltd.	SAIPARENT	2,415.06	171.06	3.16	13.9	12.97
Beta Drugs Ltd.	BETA	2,338.9	59.68	9.44	18.65	22.17

Divi's Laboratories Ltd. (DIVISLAB) has a P/E ratio of 30.28x compared with the displayed peer median of 40.11x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Divi's Laboratories Ltd. (DIVISLAB) has a market capitalisation of Rs 1,96,989.63 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching Divi's Laboratories Ltd.

• Fresh 52-week high at Rs 7,860.5, indicating positive price momentum.
• Significant market cap of Rs 1,96,989.63 Cr in the healthcare sector.
• P/E ratio above sector median, suggesting higher valuation.
• Low P/B ratio, indicating potential undervaluation.
• Negative profitability metrics, highlighting areas for improvement.

About Divi's Laboratories Ltd.

Divi's Laboratories Ltd. is a prominent player in the healthcare sector, specialising in the production of active pharmaceutical ingredients (APIs) and intermediates. The company serves a global clientele, providing high-quality products that meet stringent regulatory standards. With a focus on innovation and sustainability, Divi's Laboratories Ltd. continues to expand its market presence and enhance its product offerings.

Track Divi's Laboratories Ltd. Share Price on Univest

Use Divi's Laboratories Ltd. (DIVISLAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Investors can track Divi's Laboratories Ltd. Share Price, along with technical indicators, fundamental ratios, shareholding patterns, 52-week levels, and market insights on Univest. Stay informed with the latest data and analysis to make educated investment decisions.

Frequently Asked Questions

What is the current share price of Divi's Laboratories Ltd.?

Ans. The current share price of Divi's Laboratories Ltd. is Rs 7,860.5, marking a fresh 52-week high with a 0.85% increase from the previous close. The stock moved 0.85% during the session.

How does Divi's Laboratories Ltd.'s P/E ratio compare to the sector?

Ans. Divi's Laboratories Ltd.'s P/E ratio of 30.28 is above the sector median of 21.7, indicating a higher valuation compared to many peers. The company trades at a P/E ratio of 30.28x.

What is Divi's Laboratories Ltd.'s market capitalisation?

Ans. Divi's Laboratories Ltd. has a market capitalisation of Rs 1,96,989.63 Cr, reflecting its significant presence in the healthcare sector. The company operates in the Healthcare sector. Its P/E ratio is 30.28x.

How does Divi's Laboratories Ltd.'s P/B ratio compare to its peers?

Ans. With a P/B ratio of 0.44, Divi's Laboratories Ltd. is valued more conservatively compared to peers like Kwality Pharmaceuticals Ltd., which has a P/B of 8.17. The company trades at a P/E ratio of 30.28x.

What are the profitability metrics for Divi's Laboratories Ltd.?

Ans. Divi's Laboratories Ltd. has a negative ROE of -2.89% and a negative ROCE of -0.26%, indicating areas for potential improvement in profitability. ROE stands at -2.89%. ROCE stands at -0.26%.

How does Divi's Laboratories Ltd.'s market cap compare to sector peers?

Ans. Divi's Laboratories Ltd.'s market cap of Rs 1,96,989.63 Cr is significantly higher than the sector median of Rs 138.42 Cr, showcasing its market strength. The company operates in the Healthcare sector.

What is the sector benchmark for P/E ratio?

Ans. The sector benchmark for P/E ratio has a median of 21.7, with Divi's Laboratories Ltd. positioned above this median at 30.28. The company trades at a P/E ratio of 30.28x.

What is the 52-week high for Divi's Laboratories Ltd.?

Ans. The 52-week high for Divi's Laboratories Ltd. is Rs 7,886.55, achieved today, indicating strong price momentum. The stock moved 0.85% during the session. The intraday range extended from Rs 7,815 to Rs 7,886.55.

How does Divi's Laboratories Ltd. compare to Kwality Pharmaceuticals Ltd.?

Ans. Compared to Kwality Pharmaceuticals Ltd., Divi's Laboratories Ltd. has a lower P/E ratio of 30.28 versus 40.11 and a significantly lower P/B ratio of 0.44 versus 8.17. Comparable listed companies include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., Dr Agarwals.